Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer

Odense University Hospital30 enrolled

Overview

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected. A total of 50 patients will be included in this study. The study is approved by the local scientific ethical committee No. S-20100006

Study Type

OBSERVATIONAL

Enrollment

Conditions

Rectal Cancer

Interventions

blood sampels from vena rectalis superior and vena cubitiOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Histological verified cancer * The cancer must be located in rectum maximum of 15 cm. * Age above 18 Exclusion Criteria: * Disseminated cancer * Perioperative radio-chemotherapy * Laparoscopy surgery

Locations (1)

Vejle hospital

Vejle, Vejle, Denmark

RECRUITING

Outcomes

Primary Outcomes

The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival.

Time frame: after the study is complete

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.